SCHEMBL6076262

SCHEMBL6076262

CC(=O)NCc1c(Cc2ccco2)oc2ccc(O)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 12/20 0.56
▸ MTNR1B P49286 12/20 0.56
▸ ALDH1A1 P00352 3/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ S1PR2 O95136 1/20 0.42
▸ S1PR4 O95977 1/20 0.42
▸ ESR1 P03372 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ S1PR1 P21453 1/20 0.42
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075827 0.81 MTNR1A (0.38) MTNR1AMTNR1BALDH1A1L3MBTL1NPC1
SCHEMBL8123672 0.77 MTNR1A (0.74) MTNR1AMTNR1B
SCHEMBL8132594 0.76 MTNR1A (0.73) MTNR1AMTNR1B
SCHEMBL6075467 0.72 MTNR1A (0.36) MTNR1AMTNR1BALDH1A1L3MBTL1RAB9A
SCHEMBL8132802 0.72 MTNR1A (1.00) MTNR1AMTNR1B
SCHEMBL48668 0.70 ALDH1A1 (0.62) ALDH1A1L3MBTL1RAB9AKDM4EKMT2A
SCHEMBL8126745 0.69 MTNR1A (0.74) MTNR1AMTNR1B
SCHEMBL8128665 0.67 MTNR1A (0.51) MTNR1AMTNR1BALDH1A1L3MBTL1NPC1
SCHEMBL8116625 0.67 MTNR1A (0.56) MTNR1AMTNR1BNPC1RAB9ATDP1
SCHEMBL7019533 0.67 MTNR1A (0.87) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7126012-B2 Substituted cyclic compounds LES LABORATOIRES SERVIER (FR) 2006-10-24 — — US disclosed
US-7115752-B2 Substituted cyclic compounds LES LABORATOIRES SERVIER (FR) 2006-10-03 — — US disclosed
US-20050124682-A1 Substituted cyclic compounds LESIEUR DANIEL (FR) 2005-06-09 — — US disclosed
US-6872851-B1 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them LES LABORATORIES SERVIER (FR) 2005-03-29 — — US disclosed
US-20050059729-A1 Substituted cyclic compounds LESIEUR DANIEL (FR) 2005-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059729-A1 Substituted cyclic compounds CCNY, CCNT2, TECR MTNR1A 465/4885MTNR1B 414/4885ALDH1A1 1013/4885
US-20050124682-A1 Substituted cyclic compounds CCNY, CCNT2, TECR MTNR1A 465/4885MTNR1B 414/4885ALDH1A1 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback